@the_news_21
National Technical Advisory Group on Immunization (NTAGI) has approved Serum Institute of India’s COVID-19 vaccine Covovax for the 12-17 age group, sources told news agency ANI.
Last month, an expert panel of the country’s central drug authority recommended granting emergency use authorisation (EUA) to Covovax for the 12-17 age group.
TheNews21 is India’s independent digital news and investigative platform founded by senior journalist Vivek Bhavsar. From our Mumbai newsroom, we expose corruption, analyse political power, track governance and public policy, and report on issues that directly impact citizens. Alongside investigations, we bring credible coverage of national politics, economy, foreign affairs, business, crime, and civic matters. Our journalism stands firmly on the principles of independence, accuracy, and public interest — No Fear, No Favour.
This article had me hooked! For those curious, here’s more: DISCOVER MORE. What are your thoughts?
Dễ hiểu – xúc tích – nhiều giá trị.
Đến với J88, bạn sẽ được trải nghiệm dịch vụ cá cược chuyên nghiệp cùng hàng ngàn sự kiện khuyến mãi độc quyền.
Khám phá thế giới giải trí trực tuyến đỉnh cao tại MM88, nơi mang đến những trải nghiệm cá cược thể thao và casino sống động.